This site is intended for healthcare professionals only
LoginRegister
Shilpa Medicare ink pact to sell 31 percent stake in Sravathi Advanced Process Technologies for Rs 49.6 croreTeva to divest Teva-Takeda, its Business Venture in Japan
Zydus to commercialize Vascular Endothelial Growth Factor inhibitor Nufymco in USGilead Sciences, Tubulis ink pact to develop ADC candidate for select solid tumor target
Pfizer Slapped With Rs 8.79 Cr GST Demand Over Alleged ITC Irregularities, Plans AppealPfizer Gets CDSCO Panel Nod To Import 20 Valent Pneumococcal Conjugate Vaccine
Novartis declares positive results from phase III study for new malaria treatmentInclisiran be sold by retail under prescription of cardiologist only: CDSCO panel tells Novartis...
Advent to Sell Zentiva to Private Equity GTCR in USD 4.8 Billion Deal, Closing Expected in 2026Suven Pharma to acquire controlling stake in NJ Bio with investment of USD 64.4 million
Piramal Pharma gets 4 USFDA observations for Lexington facilityPiramal Pharma to pay USD 407400 to resolve dispute with VetDC
AstraZeneca to Invest USD 15 Billion in China by 2030AstraZeneca Imfinzi granted priority review by USFDA for muscle-invasive bladder cancer
Health Ministry Proposes Notification-Based Approval for Pharma Export BE Studies Instead of Central Licensing Authority NodAlprazolam tablets worth Rs one crore seized, 2 arrested
Drug Safety Alert: IPC Links Erythromycin Use to Fixed Drug EruptionDrug Safety Alert: IPC Flags Adverse Reactions to Amphotericin B and Carbimazole
Dr Reddys Russia Arm Slapped Rs 2.45 Cr VAT PenaltyKazakhstan authority levies Rs 28.7 lakh penalty on Dr Reddy's Labs unit
The Banjara Hills Police Book Cancer Hospital Clerk for Cheating PatientsFIR Against Aurobindo Pharma Official, Others for Alleged Rs 3,600 Crore Share Acquisition Scam
JnJ wins USFDA approval for subcutaneous Rybrevant Faspro for EGFR-Mutated NSCLCHealth Ministry Reconstitutes Expert Panel for J&J ASR Hip Implant Compensation
X